At present, there are relatively many clinical gene studies. microRNA -215 (miR-215) is a miRNA induced by p53. It exists in animals and humans. miR-215 can exist not only in tumor tissues, but also in blood, urine and feces. miR-215 is abnormally expressed in a variety of tumors and plays a role in promoting and inhibiting cancer. Therefore, miR-215 may provide a new research direction for tumor diagnosis, treatment and prognosis. This paper reviews the expression of miR-215 as a oncogene and tumor suppressor gene in tumors and in non tumors.
目的 探讨甲状腺手术中预防甲状旁腺损伤的方法。方法 回顾性分析我院从2009年1月至2011年5月期间收治的82例甲状腺手术患者的临床资料。结果 82例中行双叶甲状腺全切除术57例,一侧腺叶切除+对侧腺叶次全切除术25例。术后甲状旁腺损伤的发生率为0.24% (2/82),无永久性甲状旁腺功能低下病例发生。结论 在甲状腺手术中,保留甲状腺下动脉至关重要。保留甲状腺下动脉可保证甲状旁腺的充足血供,可很好的预防甲状旁腺的损伤。
Objective To summarize clinical application status of auxiliary heterotopic liver transplantation. Methods Reviewed relevant literatures and made a summary. Indications, contraindications, surgical treatment, therapeutic efficacy, and existing problems of auxiliary heterotopic liver transplantation were summed up. Results Main indication of auxiliary heterotopic liver transplantation is fulminant liver failure, and with no absolute contraindications. Partial liver transplantation is more popular. The therapeutic efficacy of auxiliary heterotopic liver transplantation is confirmed, but there are still some problems needed to be solved. Conclusion Auxiliary heterotopic liver transplantation is an effective method and replacement therapy for acute and chronic liver failure.